Compare Stryker Corporation (SYK) vs Vanguard Dividend Appreciation Index Fund ETF (VIG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Stryker Corporation vs Vanguard Dividend Appreciation Index Fund ETF — how do they compare? Stryker Corporation trades at $315.34 (market cap $122.35B), while Vanguard Dividend Appreciation Index Fund ETF trades at $236.97. The key difference: Stryker Corporation pays a 1% dividend while Vanguard Dividend Appreciation Index Fund ETF pays none, and Vanguard Dividend Appreciation Index Fund ETF is trading nearer its 52-week high, Stryker Corporation nearer its low. Which is the better fit depends on your goals.
| SYK | VIG | |
|---|---|---|
Market Cap | $122.35B | — |
Sector | Technology | — |
52-Week High | $403.53 | $239.13 |
52-Week Low | $282.58 | $204.09 |
Enterprise Value | $134.10B | — |
Dividend Yield | 1% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Stryker (SYK) trades at $319.14, down 0.23% on the day, with a bearish technical signal despite strong fundamentals. The company reported $25.12B revenue and $3.25B net income for 2025, maintaining robust profitability with 63.83% gross margins and 13.21% net margins. Recent Q1 2026 earnings missed expectations due to a cybersecurity disruption, but management maintained full-year guidance. Analyst consensus remains strongly bullish with a $388.44 price target and 74% buy ratings.
The stock presents a compelling opportunity for long-term investors given its strong fundamentals and innovation pipeline, though near-term technical weakness and competitive pressures warrant caution. Upside potential exists from continued Mako robotics adoption and market share gains, while risks include cybersecurity vulnerabilities and integration challenges from acquisitions.
VIG trades at $235.95, down 0.7% on the day, with a neutral technical signal and bullish moving averages. The ETF focuses on dividend growth from financially healthy U.S. large-caps, offering a low 0.04% expense ratio. Recent news highlights its role in diversifying Magnificent Seven exposure and building passive income, with a dividend scheduled for June 2026.
Outlook remains stable for long-term investors seeking quality dividend growth, though competition from higher-yield ETFs presents a risk. The neutral technical stance suggests near-term consolidation, while fundamental strength in holdings supports steady appreciation. Market sentiment is positive amid focus on reliable income strategies.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Stryker Corporation
Stryker is a global leader in medical technology, specializing in Orthopaedics, MedSurg, and Neurotechnology. It is renowned for its highly decentralized business model, which empowers 22 specialized business units to drive innovation and category leadership. With its market-leading Mako SmartRobotics™ platform and a relentless M&A strategy, Stryker provides a comprehensive ecosystem of connected surgical tools, implants, and digital solutions that improve both clinical and financial outcomes for hospitals worldwide.
Read more on SYK →About Vanguard Dividend Appreciation Index Fund ETF
The advisor employs an indexing investment approach designed to track the performance of the index, which consists of common stocks of companies that have a record of increasing dividends over time. The advisor attempts to replicate the target index by investing all, or substantially all, of its assets in the stocks that make up the index, holding each stock in approximately the same proportion as its weighting in the index.
Read more on VIG →
